These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 11877642)

  • 1. Leptin: a new growth factor for the small intestine.
    Alavi K; Schwartz MZ; Prasad R; O'connor D; Funanage V
    J Pediatr Surg; 2002 Mar; 37(3):327-30. PubMed ID: 11877642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel effect of leptin on small intestine adaptation.
    Pearson PY; O'Connor DM; Schwartz MZ
    J Surg Res; 2001 May; 97(2):192-5. PubMed ID: 11341798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagonlike peptide-2 analogue enhances intestinal mucosal mass and absorptive function after ischemia-reperfusion injury.
    Rajeevprasad R; Alavi K; Schwartz MZ
    J Pediatr Surg; 2000 Nov; 35(11):1537-9. PubMed ID: 11083417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GLP-2alpha accelerates recovery of mucosal absorptive function after intestinal ischemia/reperfusion.
    Prasad R; Alavi K; Schwartz MZ
    J Pediatr Surg; 2001 Apr; 36(4):570-2. PubMed ID: 11283879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-11 enhances small intestine absorptive function and mucosal mass after intestinal adaptation.
    Alavi K; Prasad R; Lundgren K; Schwartz MZ
    J Pediatr Surg; 2000 Feb; 35(2):371-4. PubMed ID: 10693699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental reprogramming of rat GLUT-5 requires de novo mRNA and protein synthesis.
    Jiang L; Ferraris RP
    Am J Physiol Gastrointest Liver Physiol; 2001 Jan; 280(1):G113-20. PubMed ID: 11123204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagonlike peptide-2 enhances small intestinal absorptive function and mucosal mass in vivo.
    Kato Y; Yu D; Schwartz MZ
    J Pediatr Surg; 1999 Jan; 34(1):18-20; discussion 20-1. PubMed ID: 10022136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor up-regulates SGLT1 and GLUT5 gene expression after massive small bowel resection.
    Kato Y; Yu D; Schwartz MZ
    J Pediatr Surg; 1998 Jan; 33(1):13-5. PubMed ID: 9473090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of intestinal adaptation by hepatocyte growth factor.
    Kato Y; Yu D; Schwartz MZ
    J Pediatr Surg; 1998 Feb; 33(2):235-9. PubMed ID: 9498393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-11 enhances intestinal absorptive function after ischemia-reperfusion injury.
    Kuenzler KA; Pearson PY; Schwartz MZ
    J Pediatr Surg; 2002 Mar; 37(3):457-9. PubMed ID: 11877666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfection of the sodium/glucose cotransporter into colon mucosa: a novel treatment for short bowel syndrome.
    Pearson PY; Yu D; Schwartz MZ
    J Pediatr Surg; 2002 Jul; 37(7):1076-80; discussion 1076-80. PubMed ID: 12077775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor enhances intestinal mucosal cell function and mass in vivo.
    Kato Y; Yu D; Lukish JR; Schwartz MZ
    J Pediatr Surg; 1997 Jul; 32(7):991-4. PubMed ID: 9247219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexose transporter expression in rat small intestine: effect of diet on diurnal variations.
    Corpe CP; Burant CF
    Am J Physiol; 1996 Jul; 271(1 Pt 1):G211-6. PubMed ID: 8760125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of luminal hepatocyte growth factor on small intestine mucosa in vivo.
    Kato Y; Yu D; Lukish JR; Schwartz MZ
    J Surg Res; 1997 Jul; 71(1):49-53. PubMed ID: 9271277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet effects on glucose absorption in the small intestine of neonatal calves: importance of intestinal mucosal growth, lactase activity, and glucose transporters.
    Steinhoff-Wagner J; Zitnan R; Schönhusen U; Pfannkuche H; Hudakova M; Metges CC; Hammon HM
    J Dairy Sci; 2014 Oct; 97(10):6358-69. PubMed ID: 25108868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-chain fatty acid-supplemented total parenteral nutrition alters intestinal structure, glucose transporter 2 (GLUT2) mRNA and protein, and proglucagon mRNA abundance in normal rats.
    Tappenden KA; Drozdowski LA; Thomson AB; McBurney MI
    Am J Clin Nutr; 1998 Jul; 68(1):118-25. PubMed ID: 9665105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth factor enhancement of intestinal function: dramatic response but lack of synergism.
    Kato Y; Yu D; Schwartz MZ
    J Pediatr Surg; 1997 Nov; 32(11):1598-600. PubMed ID: 9396534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats.
    Tappenden KA; Thomson AB; Wild GE; McBurney MI
    Gastroenterology; 1997 Mar; 112(3):792-802. PubMed ID: 9041241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion.
    Prasad R; Alavi K; Schwartz MZ
    J Pediatr Surg; 2000 Feb; 35(2):357-9. PubMed ID: 10693696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of inflammatory bowel disease in a rodent model with the intestinal growth factor glucagon-like peptide-2.
    Alavi K; Schwartz MZ; Palazzo JP; Prasad R
    J Pediatr Surg; 2000 Jun; 35(6):847-51. PubMed ID: 10873024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.